PACIFIC BIOSCIENCES CALIFORNIA INC

NASDAQ

PACB

Momentum is shifting down. We have multiple gaps to fill and very decent support. If we miss the short we can take longs at the red horizontal lines.

long

PACB is on a tear right now with new of an acquisition deal by their competitor Illumina for 1.2 billion dollars. According to Forbes, this is the largest deal Illumina has ever made in more than 20 years. According to other reports the deal won't be finalized till mid-2019 though, so today's price increase seems to a result of that new breaking yesterday after...

LONG BREAK UP

above 200 DMA on rising volume

PACB Swing Setup 6-16-17. Waiting for 20, 50 & 100 MA's to come back toward the 200 MA and for price to breach the 200. No position currently.

genome sequencing technology.presenting at rbc conf 22-25 nyc.

Recovery uptrend looks poised to continue following orderly pullback to support line.

is going to be a critical level of breaking point, next level pf resistence is 10 and 10.71...the others moving averages are right now at that last price

Pullback to rising 50-hourly-sma in a new recovery uptrend, possible increase in momentum.

Coiling up under R-channel line.

Looks like we have one of those 'M's popping up. Only reason I'm posting this is because a retracement at 61.8% (golden ratio or something) lines up with my other longer term bull prediction and it helps explain the recent shoot downward. Ms usually have an explosive retracement from what I've seen. Buying as soon as retracement starts to happen.

Nice steady takeoff and adherence to the curve.

Earnings winner that is ready to run some more. Nice young trend here

$PACB breakout happened today and has room to upper resistance or $11

With a 1.84 Risk/Reward ration, I'm confident with this chart staying under the resistance trend line. If if goes above resistance and closes above it; it will be time to move on.

PACB Tilted C&H & Inv H&S & Gap-Fill, Longs, Short Term 1st Gap to 5.25, Next ~C&H & Inv H&S Target @ 11